Brean Capital downgraded Xylem (NYSE: XYL) from Buy to Hold. The downgrade follows disappointing Q2 results.

"Xylem's 2Q13 EPS ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE